Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea · Delayed Price · Currency is KRW 7,910.00
-390.00 (-4.70%)
At close: Sep 11, 2026
KOSDAQ:014950 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | -1,498 | -754.89 | 3,522 | 2,969 |
Depreciation & Amortization | 1,317 | 1,376 | 1,351 | 1,278 |
Loss (Gain) From Sale of Assets | -45.47 | -45.98 | -9.5 | -0.07 |
Asset Writedown & Restructuring Costs | - | - | 23.8 | - |
Loss (Gain) From Sale of Investments | -141.79 | -348.99 | -300.14 | -298.32 |
Stock-Based Compensation | 162.8 | 122.88 | 263.58 | 72.69 |
Provision & Write-off of Bad Debts | -8.53 | -22.41 | -2.68 | -65.12 |
Other Operating Activities | 4,379 | 5,084 | 1,391 | 696.68 |
Change in Accounts Receivable | 4,000 | 3,825 | 558.63 | -1,117 |
Change in Inventory | -2,034 | -3,212 | -2,105 | -55.64 |
Change in Accounts Payable | -4,694 | -3,343 | 251.69 | -827.43 |
Change in Income Taxes | - | - | - | -3.98 |
Change in Other Net Operating Assets | -240.18 | -604.02 | -559.9 | -400.44 |
Operating Cash Flow | 1,198 | 2,077 | 4,385 | 2,248 |
Operating Cash Flow Growth | -50.60% | -52.64% | 95.04% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -3,593 | -3,423 | -842.32 | -1,374 |
Cash Acquisitions | 187.9 | 187.9 | - | - |
Sale (Purchase) of Intangibles | -34.58 | -8.69 | -5.83 | -3.14 |
Investment in Securities | 4,467 | 2,267 | -1,613 | -120.5 |
Other Investing Activities | 121.3 | -21.95 | - | -70 |
Investing Cash Flow | 1,084 | -1,153 | -2,161 | -1,868 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Long-Term Debt Repaid | - | -85.93 | -137.56 | -109.02 |
Net Debt Issued (Repaid) | -91.49 | -85.93 | -137.56 | -109.02 |
Issuance of Common Stock | 597.65 | 131.66 | 672.3 | - |
Repurchase of Common Stock | -15.73 | -15.73 | - | - |
Dividends Paid | -403.67 | -285.97 | -281 | -140.5 |
Other Financing Activities | -4.38 | - | -1.02 | - |
Financing Cash Flow | 82.38 | -255.98 | 252.72 | -249.52 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Foreign Exchange Rate Adjustments | 1.72 | 1.28 | - | - |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 |
Net Cash Flow | 2,366 | 669.13 | 2,477 | 130.88 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -2,395 | -1,346 | 3,543 | 874.05 |
Free Cash Flow Growth | - | - | 305.32% | - |
Free Cash Flow Margin | -3.85% | -2.24% | 6.34% | 1.71% |
Free Cash Flow Per Share | -271.95 | -177.44 | 503.91 | 124.52 |
Levered Free Cash Flow | -2,386 | -2,343 | 3,382 | - |
Unlevered Free Cash Flow | -2,349 | -2,325 | 3,389 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 12.96 | 8.99 | 12.04 | 18.36 |
Cash Income Tax Paid | 941.78 | 599.17 | 205.69 | 3.03 |
Change in Working Capital | -2,968 | -3,334 | -1,854 | -2,405 |